MicroRNAs' Significance in Retinoblastoma Diagnosis and Treatment: The Little Heroes
- 25 January 2025
- journal article
- research article
- Published by Springer Nature in Biochemical Genetics
- Vol. 63 (2) , 1176-1197
Abstract
One in 16, 000 live births is affected by the retinal tumor RB (retinoblastoma), which is frequently found in a child’s early years. Both of the RB1 alleles that have been locally mutated in the affected retina are present in 60 percent of cases. Retinoblastoma (RB) can be detected using a variety of techniques, including imaging of the brain and orbits, eye examinations under anesthesia (EUAs), and the discovery of cell-free tumor DNA in samples of aqueous humor or plasma. In addition to the conventional surgical, chemotherapy, and radiotherapy approaches to treating retinoblastoma, new approaches have also been developed. Oncogenes, genes of tumor suppressors, and other molecular elements involved in cell growth and division interact complexly during the pathogenesis of retinoblastoma. The development of new therapies depends on comprehending the function of these molecular components. As a small class of non-coding RNAs capable of altering gene expression, microRNAs (miRNA) are understood to represent potential targets for the treatment of cancer. This study aimed to describe the changes in microRNA expression in some types of cancer, with a particular focus on retinoblastoma. Graphical Abstract Molecular mechanism of microRNA targeting: a promising approach for retinoblastoma diagnosis and treatment. The pathogenesis of retinoblastoma involves a complex interaction between tumor suppressor genes, oncogene, and other molecular components involved in cell growth and divisionKeywords
This publication has 90 references indexed in Scilit:
- Role of MicroRNAs in Cell Growth Proliferation and Tumorigenesis2022
- LncRNA MBLN1-AS1 inhibits the progression of retinoblastoma through targeting miR-338-5p-Wnt/β-catenin signaling pathwayInflammation Research, 2021
- Cell‐free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experienceCancer Medicine, 2020
- Enucleated globes with advanced retinoblastoma: correlation of histopathological features and reclassification of tumors according to the 8th edition of the American Joint Committee on Cancer (AJCC)International Ophthalmology, 2020
- MicroRNA‐598 acts as an inhibitor in retinoblastoma through targeting E2F1 and regulating AKT pathwayJournal of Cellular Biochemistry, 2019
- Role of miRNAs in immune responses and immunotherapy in cancerGenes, Chromosomes and Cancer, 2018
- Expression profiles and prognostic value of miRNAs in retinoblastomaJournal of Cancer Research and Clinical Oncology, 2018
- Suppression of Disheveled–Axin Domain Containing 1 (DIXDC1) by MicroRNA-186 Inhibits the Proliferation and Invasion of Retinoblastoma CellsJournal of Molecular Neuroscience, 2017
- MicroRNAs in retinoblastoma: Potential diagnostic and therapeutic biomarkersJournal of Cellular Physiology, 2017
- miRNAs: micro-managers of anticancer combination therapiesAngiogenesis, 2017